Equity Research, Broker Reports, and media content on IMMUNE PHARMACEUTICALS INC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about IMMUNE PHARMACEUTICALS INC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on IMMUNE PHARMACEUTICALS INC. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
28Nov16 10:45 PRN Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Shire
22Nov16 02:00 PRN Immune Pharmaceuticals Announces Immuno-Oncology R&D Update on December 8, 2016
17Nov16 02:15 PRN Immune Pharmaceuticals Secures Up to $11 Million in New Financing to be Deployed With a Focus on Bertilimumab Clinical Development
17Oct16 02:23 PRN Immune Pharmaceuticals Announces Formation of Management Team for Maxim Pharmaceuticals, its Pain and Neurology Subsidiary
17Oct16 10:00 PRN Healthcare Stocks Technical Reports -- Immune Pharma, Sanofi, Shire, and Nobilis Health
26Sep16 02:00 PRN The Bioscience and Biotechnology Sector Developments in Cancer Therapy
16Sep16 12:30 PRN Immune Pharmaceuticals Signs Agreement to Fund Maxim Pharmaceuticals, Inc., its Pain and Neurology subsidiary
  • Frequency of research reports


  • Research reports on


  • Providers covering